deferoxamine has been researched along with colchicine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Farber, JL; Kyle, ME; Sakaida, I | 1 |
| Boughton-Smith, NK; Deakin, AM; Follenfant, RL; Garland, LG; Whittle, BJ | 1 |
| May, JM; Qu, ZC | 1 |
1 review(s) available for deferoxamine and colchicine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for deferoxamine and colchicine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress.
Topics: Adenine; Amino Acids; Animals; Ascorbic Acid; Autophagy; Benzyl Alcohol; Benzyl Alcohols; Cell Survival; Cells, Cultured; Colchicine; Deferoxamine; Ferric Compounds; Ferritins; Liver; Methylamines; Oligomycins; Oligopeptides; Oxidation-Reduction; Peroxides; Phagocytosis; Proteins; Rats; Rats, Inbred Strains; tert-Butylhydroperoxide | 1990 |
Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Antioxidants; Arachidonic Acid; Arthus Reaction; Carrageenan; Colchicine; Cyclooxygenase Inhibitors; Deferoxamine; Dexamethasone; Edema; Lipoxygenase Inhibitors; Male; Peroxidase; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase | 1993 |
Chelation of intracellular iron enhances endothelial barrier function: a role for vitamin C?
Topics: 2,2'-Dipyridyl; Ascorbic Acid; Capillary Permeability; Cell Line; Colchicine; Collagen; Cytochalasin B; Cytoskeleton; Deferoxamine; Endothelial Cells; Fluorescent Dyes; Glutathione; Humans; Hydroxybenzoates; Inulin; Iron; Iron Chelating Agents; Organic Chemicals; Oxyquinoline | 2010 |